Skip Navigation

COVID-19 Update

Practice Location

Add a Location+


Add a Language+
  • A

Doctor's Gender

Profile Results for End Stage Liver Disease

Displaying 1 to 10 of 12
  1. 1
  2. 2

Results per page: 10 ·  20 

  • Jacqueline Marie Laurin, M.D.

    of patients with end stage liver disease? The American Journal...

    Dr. Jacqueline M. Laurin is a transplant hepatologist of Sibley Memorial Hospital’s Hepatology Multidisciplinary Center, as well as an assistant professor of medicine at Johns Hopkins University School of Medicine. She is board certified in gas...
  • Ahmet Omur Gurakar, M.D.

    Digestive Disorders, Elevated Liver Tests, End Stage Liver Disease, Fatty Liver, Gastroenterology, Hepatitis, Jaundice, Liver Cancer, Liver Disease, Liver Mass, Liver Test Abnormalities, Liver Transplant, Nonalcoholic Fatty Liver Disease, Sclerosing Cholangitis

    Dr. Gurakar joined Johns Hopkins from the Nazih Zuhdi Transplantation Institute at the Integris Baptist Medical Center in Oklahoma City, where he was the chief of Hepatology Research and the program director of the Liver Transplantation Medicine/ Hep...
  • William Thomas Merritt, M.B.A., M.D.

    Interests Hemodynamics of end-stage liver disease; Metabolism in end-stage liver disease; Blood substitutes and...

    Dr. William Merritt is an associate professor of anesthesiology and critical care medicine and surgery at the Johns Hopkins University School of Medicine. He is an expert in anesthesiology and transplant surgery. Dr. Merritt serves as the director of...
  • Andrew MacGregor Cameron, M.D., Ph.D.

    Expertise Abdominal Surgery, End Stage Liver Disease, Hepatobiliary Surgery, Hepatocellular Cancer, Liver Cancer, Liver Disease, Liver Transplant, Pancreas Transplant, Pediatric Liver Transplant, Transplant Surgery...

    Dr. Cameron was born at Johns Hopkins and raised in Baltimore. He attended Harvard College and returned to Johns Hopkins where he obtained his MD and PhD degrees.  His surgical training was spent at the Massachusetts General Hospital and then at...
  • Doris Da May Lin, M.D., Ph.D.

    high model for end-stage liver disease (MELD) scores: a...

    Dr. Doris Da May Lin is an Associate Professor in the Johns Hopkins Medicine Department of Radiology and Radiological Science. She specializes in neuroradiology.Dr. Lin received her B.A. in chemistry from the University of Pennsylvania, and then purs...
  • Rebecca Lynn Ruebner, M.D., M.S.C.E.

    Risk Factors for End-Stage Kidney Disease after Pediatric Liver Transplantation. American Journal...

    Dr. Rebecca Ruebner is an assistant professor of pediatrics at the Johns Hopkins University School of Medicine. She provides care for children with kidney problems of any type including hypertension, hematuria, proteinuria, kidney stones, chronic kid...
  • Ihab Roushdy Kamel, M.D., Ph.D.

    Bluemke DA.Surgically staged focal liver lesions: Accuracy and...

    Dr. Ihab Kamel is a Professor in the Johns Hopkins Medicine Department of Radiology and Radiological Science and the Department of Oncology. Dr. Kamel served as the Clinical Director of MRI at Johns Hopkins University until December 2019.  He cu...
  • Michael Gilbert Goggins, M.B.B.Ch., M.D.

    Bloating, Cancer, Celiac Disease, Chest Pain, Clinical...

    Dr. Michael G. Goggins is a professor of pathology, medicine and oncology at the Johns Hopkins University School of Medicine. He serves as director of the Pancreatic Cancer Early Detection Laboratory and is an attending physician in medicine in the D...
  • Graham Wester Redgrave, M.D.

    to Huntington's disease stage." Cortex 49( gastroenterology and liver disease. T. M. Bayless

    Dr. Redgrave received his B.A. from St. John's College and his M.D. from the Johns Hopkins University School of Medicine. He completed an internship in general internal medicine at Johns Hopkins Bayview Medical Center and psychiatric residency at Joh...
  • Elizabeth Marion Jaffee, M.D.

    associated with improved disease-free survival in...pancreas to the liver and other organs

    Dr. Elizabeth M. Jaffee is an international leader in the development of immune based therapies for pancreatic and breast cancers.  In 1981, she graduated magna cum laude from Brandeis University before receiving her medical degree from New York...
  1. 1
  2. 2
back to top button